Insider screener

Period: 12 months Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,452 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,452 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,452 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,452 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,452 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,452 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,452 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
6 Mar 2026
Curtis Liu Chief Technology Officer
Sold on a plan
$265.84K 33,201 at 8.01
5.2%
Planned (10b5-1)
6 Mar 2026
L Reade Fahs Executive Chairman
Sold on a plan
$224.84K 7,601 at 29.58
1.1%
Planned (10b5-1)
6 Mar 2026
Chad Michael Whalen EVP, Worldwide Sales
Sold on a plan
$190.61K 688 at 277.05
2.5%
Planned (10b5-1)
6 Mar 2026
Peter McNamara Chief Scientific Officer
Sold on a plan 2×
$188.94K 6,262 at 30.17
10.2%
Planned (10b5-1)
6 Mar 2026
Sold on a plan 2×
$158.67K 33,438 at 4.75
2.2%
Planned (10b5-1)
6 Mar 2026
Christopher Mutz Head of Rare Disease
Sold on a plan
$157.42K 2,121 at 74.22
2.0%
Planned (10b5-1)
6 Mar 2026
William Mariner Greenman President and CEO
Sold on a plan
$156.80K 78,187 at 2.01
1.4%
Planned (10b5-1)
6 Mar 2026
Mary Celeste Fruge VP, General Counsel
Sold on a plan
$149.30K 11,193 at 13.34
4.0%
Planned (10b5-1)
6 Mar 2026
Mike Zoi 10% owner · indirect
Sold on a plan
$137.35K 29,224 at 4.70
2.3%
Planned (10b5-1)
6 Mar 2026
Timothy McKeon Senior VP and Treasurer
Sold on a plan
$132.19K 3,846 at 34.37
4.5%
Planned (10b5-1)
6 Mar 2026
L Reade Fahs Executive Chairman · indirect
Sold on a plan
$120.38K 4,071 at 29.57
1.1%
Planned (10b5-1)
6 Mar 2026
Olivia Nottebohm Chief Operating Officer
Sold on a plan
$118.90K 4,612 at 25.78
1.0%
Planned (10b5-1)
6 Mar 2026
Krista Davis SVP, Chief HR Officer
Sold on a plan
$111.38K 1,485 at 75.00
2.5%
Planned (10b5-1)
6 Mar 2026
Judy D. Olian Director
Sold on a plan
$102.00K 200 at 510.00
4.1%
Planned (10b5-1)
6 Mar 2026
Claire Mazumdar Chief Executive Officer
Sold on a plan
$71.57K 3,817 at 18.75
1.1%
Planned (10b5-1)
6 Mar 2026
Sold on a plan 3×
$70.60K 403 at 175.19
1.7%
Planned (10b5-1)
6 Mar 2026
Vivek K Jayaraman Chief Operating Officer
Sold on a plan
$68.38K 34,094 at 2.01
1.8%
Planned (10b5-1)
6 Mar 2026
Chrystal Jensen Chief Legal Officer
Sold on a plan
$61.86K 30,845 at 2.01
2.8%
Planned (10b5-1)
6 Mar 2026
Joseph R Nachman Chief Operating Officer
Sold on a plan
$60.45K 2,499 at 24.19
0.8%
Planned (10b5-1)
6 Mar 2026
Kevin Dennis Green Chief Financial Officer
Sold on a plan
$55.74K 27,796 at 2.01
2.3%
Planned (10b5-1)
6 Mar 2026
Richard J Benjamin Chief Medical Officer
Sold on a plan
$48.60K 24,235 at 2.01
2.6%
Planned (10b5-1)
6 Mar 2026
Kuanling Amy Yeh Chief Technology Officer
Sold on a plan
$31.02K 3,000 at 10.34
0.8%
Planned (10b5-1)
6 Mar 2026
Stephanie Ann Sentell Chief Operations Officer
Sold on a plan
$21.06K 225 at 93.60
1.4%
Planned (10b5-1)
6 Mar 2026
Gokul Rajaram Director
Sold on a plan
$21.00K 1,050 at 20.00
3.4%
Planned (10b5-1)
6 Mar 2026
Sold on a plan
$7.81K 608 at 12.84
1.7%
Planned (10b5-1)
6 Mar 2026
Derek M Meisner Chief Legal Officer & Corp Sec
Sold on a plan
$6.81K 2,090 at 3.26
1.2%
Planned (10b5-1)
6 Mar 2026
Bought on a plan
$4.06K 185 at 21.96
0.4%
Bought on a plan
6 Mar 2026
Sold on a plan
$3.04K 1,560 at 1.95
8.0%
Planned (10b5-1)
6 Mar 2026
Bought on a plan
$461.06 21 at 21.96
0.2%
Bought on a plan
5 Mar 2026
Anthony Guzzi Chairman, President and CEO
Sold on a plan
$26.26M 36,000 at 729.48
17.5%
Planned (10b5-1)
5 Mar 2026
David A Duffield 10% owner
Sold on a plan 5×
$15.82M 107,500 at 147.16
50.6%
Sold half or more
5 Mar 2026
William L Meaney President and CEO
Sold on a plan 3×
$10.48M 98,657 at 106.25
100%
Sold half or more
5 Mar 2026
Patrizio Vinciarelli Chairman and CEO
Sold on a plan 24×
$9.34M 50,000 at 186.83
0.5%
Planned (10b5-1)
5 Mar 2026
Michelle Zatlyn President and Board Co-Chair · indirect
Sold on a plan 5×
$4.86M 25,641 at 189.50
42.6%
Planned (10b5-1)
5 Mar 2026
Martine A Rothblatt Chairperson & CEO
Sold on a plan 9×
$4.60M 9,500 at 484.55
98.7%
Sold half or more
5 Mar 2026
Janel Riley Chief Accounting Officer
Sold on a plan
$4.43M 23,332 at 190.00
29.1%
Planned (10b5-1)
5 Mar 2026
Paul A Mahon EVP & General Counsel
Sold on a plan 9×
$4.01M 8,300 at 483.16
18.4%
Planned (10b5-1)
5 Mar 2026
Sold on a plan 4×
$3.69M 20,000 at 184.59
6.4%
Planned (10b5-1)
5 Mar 2026
John E Breeden Chief Delivery Officer
Sold on a plan
$3.55M 68,707 at 51.73
43.2%
Planned (10b5-1)
5 Mar 2026
Sarah Blake SVP, Chief Accounting Officer
Sold on a plan 3×
$3.55M 300,000 at 11.85
100%
Sold half or more
5 Mar 2026
Bruce Lucas Chief Executive Officer · indirect
Sold on a plan
$3.34M 172,644 at 19.37
0.4%
Planned (10b5-1)
5 Mar 2026
Andrea Mitchell Director
Sold on a plan 14×
$3.23M 15,000 at 215.12
41.1%
Planned (10b5-1)
5 Mar 2026
Johannes Jacob Pieter Kastelein Chief Scientific Officer · indirect
Sold on a plan
$3.17M 104,467 at 30.30
60.1%
Sold half or more
5 Mar 2026
Kevin J Mitchell Exec. VP and CFO
Sold on a plan
$2.84M 16,856 at 168.22
14.8%
Planned (10b5-1)
5 Mar 2026
Jane Prior Chief Marketing Officer
Sold on a plan 3×
$2.65M 50,000 at 52.92
28.2%
Planned (10b5-1)
5 Mar 2026
Sold on a plan
$2.63M 70,000 at 37.58
25.4%
Planned (10b5-1)
5 Mar 2026
Ishbia Mat President and CEO · indirect
Sold on a plan
$2.60M 632,874 at 4.11
9.4%
Planned (10b5-1)
5 Mar 2026
Japan Post Holdings Co., Ltd. 10% owner · indirect
Sold on a plan 2×
$2.14M 19,300 at 110.96
0.0%
Planned (10b5-1)
5 Mar 2026
Marc N Casper Chairman & CEO
Sold on a plan 13×
$2.06M 4,000 at 514.82
3.1%
Planned (10b5-1)
5 Mar 2026
Scott H Keeney President and CEO
Sold on a plan
$2.00M 32,239 at 61.96
1.4%
Planned (10b5-1)
Showing 15,401–15,450 of 23,452. ← Newer Page 309 of 470 Older →